Error: Could not add to watchlist. X

Summit Therapeutics PLC

+ Watchlist
SUMM:LN
London
149.50
GBp
1.50
1.01%
As of 11:30:00 ET on 09/01/2015.
Open
148.00
Day Range
147.00 - 149.50
Volume
37,514
Previous Close
148.00
52Wk Range
107.00 - 185.00
1 Yr Return
-9.67%
Open
148.00
Day Range
147.00 - 149.50
Volume
37,514
Previous Close
148.00
52Wk Range
107.00 - 185.00
1 Yr Return
-9.67%
YTD Return
10.33%
Current P/E Ratio (TTM)
-
Earnings per Share (GBP) (TTM)
-0.26
Market Cap (m GBp)
90.404
Shares Outstanding (m)
61.291
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Summit Therapeutics PLC is a drug discovery and development Company targeting areas of high unmet medical need. The Company is advancing two clinical-stage programmes: Utrophin modulators for the treatment of all genetic forms of the fatal disease, Duchenne Muscular Dystrophy, and a novel antibiotic for the selective treatment of infections caused by C. difficile bacteria.
ADDRESS
85b Park Drive Milton Park
Abingdon, Oxfordshire
Oxfordshire
United Kingdom
PHONE
44-123-544-3939
  • Glyn O Edwards
    Chief Executive Officer
  • Erik Ostrowski
    Chief Financial Officer
  • Jonathon Tinsley
    Chief Scientific Officer
  • Richard Vickers
    Chief Scientific Officer
  • Bina Tejura
    VP:Clinical Development
Show More